Upload
derek-allison
View
213
Download
0
Tags:
Embed Size (px)
Citation preview
NIAID/DAIDS
Future Use of Stored Samples & Data and the NIH Policy on GWAS and dbGaP
Dione Washington, M.S. -- ProPEPSudha Srinivasan, Ph.D.-- TRP
Tanisha Savage-- ProPEP (HJF-DAIDS)
DAIDS Regional Training Event 2012Johannesburg, South Africa
NIAID/DAIDS
To inform stakeholders about the NIH Policy on GWAS and dbGaP and trends in genetic research.
To describe the implications for future use of stored samples & data.
Objectives
NIAID/DAIDS
NIH GWAS Policy and dbGaP Guidelines
NIAID/DAIDS
The database of Genotypes and Phenotypes (dbGaP) was developed to archive and
distribute the results of studies that have investigated the interaction of genotype
and phenotype.
NIAID/DAIDS
Data Deposition in dbGAP
All studies funded after Jan 25, 2008 are subject to data deposition as per NIH GWAS policy guidelines
Studies funded prior to this date are not required to do so, but NIH believes in data sharing and would like the investigators to do so if possible
NIAID/DAIDS
What is in dbGAP?
Includes individual level phenotype /exposure such as height, weight, blood pressure, blood glucose (diabetes) and others…Genotype and sequence dataAssociations between clinical/ phenotypic data such as blood pressure, height, weight., etc. and genotype and sequence dataCan be for individuals or groups of peopleDE-IDENTIFIED data at all levels
NIAID/DAIDS
Types of data in dbGAP
[1] Study documentation, including study description, protocol documents, questionnaires
[2] phenotypic data for each variable assessed-individual and summary form
[3] genetic data, including individual study subjects’ genotypes and sequence data
[4] statistical results including association and linkage analyses, when available
NIAID/DAIDS
Data Sharing
Data submitted for the GWAS repository has to be coded and de identified by the submitting investigatorInvestigator retains the key to the code that would link to specific individuals or groups.NIH would never receive the code or any other information that would enable the identification of the individuals
NIAID/DAIDS
Data de-identificationDATA needs to de identified, and the 18 identifiers enumerated at section 45C.F.R. 164.514 (b) (2) –HIPAA privacy rule enacted in 1996 have to be removed
IRBs/Privacy Board officials of the submitting institutions are responsible for ensuring that data submission is in compliance of NIH policy
NIAID/DAIDS
Data Access Committee (DAC)
Adjudicating or oversight group for the GWAS policy
grants access to controlled data in dbGAP, assures appropriate data use
Data Access Committee is comprised of individuals with different technical and ethical expertiseUsers wishing access to controlled data must submit a Data Use Certification (DUC) which must be approved by the DAC committee
NIAID/DAIDS
Data access: Who can access the data and how?
Tiered data access Public and Authorized usersVetting process by DAC committee and approved before given access eRA commons ID needed for accessForeign investigators must have eRA account or collaborate with other investigator who does
NIAID/DAIDS
Why do we need to share GWAS and other data?
GWAS particularly powerful for the study of common complex diseases, where the individual genetic contributions to the disease are expected to be relatively weak
GWAS most informative when the study population is large- the larger the population, the greater the statistical power to find real associations and address multiple research hypotheses…
NIAID/DAIDS
Data SecurityVery secure
Data only released in encrypted files to authorized users
Each scientist using the data is responsible for establishing a secured facility for local use of the data
NIAID/DAIDS
What’s next after GWAS? New but similar NIH Policy
for….Sequencing: Exome, Deep, Whole Genome Sequencing……‘OMICS’ EraGenomicsTranscriptomicsProteomics ………..
NIAID/DAIDS
Description of the Stored Samples Consent Template
NIAID/DAIDS
Meets:45 CFR 46.116 and 117
21 CFR 50.25 and 27 (if applicable)
NIH Policy for GWAS and dbGaP
DAIDS Policy
Addresses:Best practices and future trends in genetics research
Use of samples and data in future research
Fully Compliant
NIAID/DAIDS
Element 1: Involves research and describes procedures.
Describe the purpose of this studyDiscover genetic changes associated with HIV/AIDS
Collection of additional (e.g. blood/body fluids/tissue) for future genetic testing, sequencing, and use in research
Basic Elements of Informed Consent
NIAID/DAIDS
Element 2: Describes foreseeable risks and discomforts
Physical RisksPossible side effects from drawing the blood sample include mild pain, bleeding, bruising, and infection at the site of the needle insertion
Psychological or Social Risks Associated with Loss of Privacy
Loss of privacyRisk associated to genetic research
Basic Elements of Informed Consent
NIAID/DAIDS
Element 3: Describes reasonably expected benefits
There may be no direct benefitNew and improved medical care, treatment and prevention of this HIV/ AIDS for others based on genetic result(s)This study may increase overall understanding about HIV/AIDS
Basic Elements of Informed Consent
NIAID/DAIDS
Element 4: Discloses alternatives to participating in the research
An alternative option is not to participate
Elect not to grant permission for storage of samples (e.g. blood/body fluids/tissue)
An alternative option is to withdraw consent
Basic Elements of Informed Consent
NIAID/DAIDS
Element 5: States how confidentiality is maintained
Describe how research study data would be used, stored, and/or shared
Describe the level of confidentiality (e.g., identifiable, coded, or anonymized samples)
Basic Elements of Informed Consent
NIAID/DAIDS
Element 6: Explains compensation and available medical treatment
Indicate what participants will receive for their participation in this studyClearly state there will be no financial compensation for products from study related samplesIf injury occurs, describe whether medical treatments are available and where further information may be obtained
Basic Elements of Informed Consent
NIAID/DAIDS
Element 7: List contact for research related questions
Element 8: States voluntariness and no loss of benefits
Basic Elements of Informed Consent